389
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Treatment modalities for pityriasis rubra pilaris subtypes: a review

ORCID Icon &
Pages 587-588 | Received 29 Jan 2020, Accepted 08 Feb 2020, Published online: 30 Mar 2020

References

  • Bonomo L, Raja A, Tan K, et al. Successful treatment of juvenile Pityriasis rubra pilaris with ustekinumab in a 7-year-old girl. JAAD Case Rep. 2018;4(2):206–210.
  • Feldmeyer L, Mylonas A, Demaria O, et al. Interleukin 23-helper T cell 17 axis as a treatment target for pityriasis rubra pilaris. JAMA Dermatol. 2017;153(4):304–308.
  • Heibel M, Heibel H. Successful treatment of type I pityriasis rubra pilaris with ixekizumab. JAAD Case Rep. 2018;4(8):774–776.
  • Ivanova K, Itin P, Haeusermann P. Pityriasis rubra pilaris: treatment with biologics – a new promising therapy? Dermatology. 2012;224(2):120–125.
  • Allison D, el-Azhary R, Calorisi S, et al. Pityriasis rubra pilaris in children. J Am Acad Dermatol. 2002;47(3):386–389.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.